Efficacy and Safety of Ertugliflozin in Patients With Diabetes Mellitus Inadequately Controlled by Sulfonylurea Monotherapy: a Substudy of VERTIS CV

INTRODUCTION: Sulfonylureas (SU) are commonly used antihyperglycemic agents. VERTIS CV was the cardiovascular outcome study for the sodium-glucose cotransporter 2 inhibitor ertugliflozin. Enrollment of patients in VERTIS CV occurred in two sequential cohorts (Cohort 1 and Cohort 2). METHODS: This su...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Diabetes Ther
Main Authors: Strojek, Krzysztof, Pandey, A. Shekhar, Dell, Vanessa, Sisson, Melanie, Wang, Shuai, Huyck, Susan, Liu, Jie, Gantz, Ira
Format: Artigo
Jezik:Inglês
Izdano: Springer Healthcare 2021
Teme:
Original Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7994479/
https://ncbi.nlm.nih.gov/pubmed/33694093
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-021-01018-w
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki